Clinical Trials Browser

Uterine Cervical Diseases × Gynecologic × 1 year × Clear all

Uterine Cervical Diseases, Uterine Cervical Neoplasms

NCT06952660 2026-04-20

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT05870787 2026-02-10

MEDIATOR

Completed

929 enrolled

Gynecologic

Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06815939 2026-01-29

OPTICS

Phase NA Recruiting

10,000 enrolled

GynecologicOther neoplasm

Urogenital Diseases, Genital Diseases, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Precancerous Conditions, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT05341284 2025-08-14

HPV-RWS

Withdrawn

Gynecologic

Uterine Cervical Diseases, Papillomavirus Infections

NCT05453006 2025-07-10

Isbaar

Phase NA Completed

3,367 enrolled 8 charts

Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, DNA Virus Infections, Infections, Papilloma, Tumor Virus Infections, Uterine Diseases, Virus Diseases, Papillomavirus Infections

NCT02956031 2025-07-08

DiaVACCS

Recruiting

1,500 enrolled

Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Diseases, Uterine Cervical Neoplasms

Clinical Trials

RIDECA

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

MEDIATOR

OPTICS

HPV-RWS

Isbaar

DiaVACCS